| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_ZNF292_0002800 | Intron-Exon-Intron | chr6:87910669-87928449 | chr6:87200951-87218731 | 250 nt | 0.3280 |
| hsa_ZNF292_0002900 | Intron-Exon-Intron | chr6:87910669-87955362 | chr6:87200951-87245644 | 279 nt | 0.3656 |
| hsa_ZNF292_0003100 | Intron-Intron | chr6:87913196-87920316 | chr6:87203478-87210598 | 254 nt | 0.4606 |
| hsa_ZNF292_0003200 | Intron-Exon-Intron | chr6:87913196-87928449 | chr6:87203478-87218731 | 215 nt | 0.4326 |
| hsa_ZNF292_0003300 | Intron-Exon-Intron | chr6:87913196-87932612 | chr6:87203478-87222894 | 106 nt | 0.3868 |
| hsa_ZNF292_0003400 | Intron-Exon-Intron | chr6:87913196-87943245 | chr6:87203478-87233527 | 106 nt | 0.3868 |
| hsa_ZNF292_0003000 | Intron-Exon-Intron | chr6:87913196-87943368 | chr6:87203478-87233650 | 250 nt | 0.2440 |
| hsa_ZNF292_0003500 | Intron-Exon-Intron | chr6:87913196-87955362 | chr6:87203478-87245644 | 142 nt | 0.3310 |
| hsa_chr6_0687300 | Intergenic-Intergenic | chr6:87913609-87913791 | chr6:87203891-87204073 | 183 nt | 0.4262 |
| hsa_ZNF292_0003600 | Intron-Intron | chr6:87915784-87915935 | chr6:87206066-87206217 | 152 nt | 0.4474 |
A study in mice demonstrated that the circZNF292 is hypoxia-induced and regulates Wnt/β-catenin pathway components to promote glioma proliferation and tube formation [Mehta et al. DOI:10.1016/j.pneurobio.2020.101746]. In rat models of myocardial ischemia, the circZNF292 was highly expressed following oxygen glucose deprivation treatment, and its overexpression was shown to release OGD-induced damage [Tian et al. DOI:10.3390/molecules26041155]. A study in human hepatoma cells demonstrated that the circZNF292 promotes hypoxic cell proliferation, vasculogenic mimicry, and radioresistance via the Wnt/β-catenin pathway, and induces tube formation and spheroid sprouting in endothelial cells [Huang et al. DOI: 10.3390/cells11091381]. Research in human glioma cells further showed that the circZNF292 is hypoxia-induced and regulates Wnt/β-catenin pathway components to promote proliferation and tube formation [Mehta et al. DOI: 10.1016/j.pneurobio.2020.101746].